Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Not applicableUnknownNCT05508555
What this trial is testing

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaChemotherapy Effect
Ain Shams University 50
Not applicableStudy completedNCT04775446
What this trial is testing

Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy

Who this might be right for
Malignant Pleural Mesothelioma
Centre Hospitalier Intercommunal Creteil 116
Not applicableEnded earlyNCT01188486
What this trial is testing

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Who this might be right for
Lung CancerLung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer Small Cell Lung Cancer (SCLC)+1 more
Stanford University 12
Not applicableLooking for participantsNCT06536179
What this trial is testing

New Preclinical and Clinical Approaches to Mesothelioma

Who this might be right for
Mesothelioma
Marco Emilio Bianchi 70
Early research (Phase 1)Study completedNCT00280982
What this trial is testing

Dendritic Cell-based Immunotherapy in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Erasmus Medical Center 10
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Early research (Phase 1)Active Not RecruitingNCT03546426
What this trial is testing

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Who this might be right for
Mesothelioma, MalignantPD-L1 NegativeAdvanced Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Not applicableUnknownNCT02761863
What this trial is testing

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 100
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Not applicableEnded earlyNCT00748085
What this trial is testing

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

Who this might be right for
Lung CancerMesothelioma
CSA Medical, Inc. 5
Not applicableUnknownNCT01719068
What this trial is testing

Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos

Who this might be right for
MesotheliomaLung Cancer
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Study completedNCT02497508
What this trial is testing

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT02078700
What this trial is testing

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Who this might be right for
Lung CancerMesotheliomaPancreas Cancer+1 more
Azienda USL Reggio Emilia - IRCCS 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602946
What this trial is testing

SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma

Who this might be right for
Mesothelioma
University of Southampton 30
Not applicableStudy completedNCT00897247
What this trial is testing

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Who this might be right for
Malignant MesotheliomaPulmonary Complications
Barbara Ann Karmanos Cancer Institute 494
Testing effectiveness (Phase 2)UnknownNCT00794859
What this trial is testing

Sorafenib in Previously Treated Malignant Mesothelioma

Who this might be right for
Mesothelioma
King's College London 54
Next Page